Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

PET/CT contrast debate: ‘Time to unleash the full power’ vs. ‘More is not always better’

Hybrid PET/CT enhanced with intravenous CT contrast deserves wider acceptance and adoption, as diagnostically optimized CT can complement PET—and vice versa—for a variety of potential indications. That’s one opinion on the matter.

As war in Ukraine continues, it's business as usual for many U.S. healthcare companies in Russia

Since the Russian invasion of Ukraine began in late February, the Yale School of Management has been tracking more than 1,200 companies that do business in Russia.

Iodine contrast being loaded into a contrast injector in preparation for a cardiac CT scan at Duly Health and Care in Lisle, Illinois. The contrast shortage is causing some healthcare organizations to postpone exams and procedures and ration contrast supplies. Photo by Dave Fornell

ACR working with FDA and HHS to help address imaging contrast shortage

The American College of Radiology (ACR) announced this week its government relations staff has been engaging federal agencies in an effort to improve product availability and hasten resolution of the ongoing iodine contrast shortage.

lung cancer pulmonary nodule

Pulmonary embolism AI cleared

A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.

Thumbnail

Mammography AI intercepts density overestimations

Researchers have demonstrated a deep learning model that can correct course for breast radiologists who otherwise may have erroneously deemed tissue dense in screening exams.

Anagrelide capsules FDA recall Teva Pharmaceuticals USA

FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes

The medication failed a routine dissolution test, meaning it could lose its effectiveness. 

FDA posts guidance on managing risk of drug shortages

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

9 ways to lift clinician completion of radiologist recommendations

A multidisciplinary panel convened by the ACR has developed a set of quality measures aimed at boosting rates of appropriate follow-up care for patients with noncritical but actionable incidental findings.

Displaying 2001 - 2008 of 3875
Design by Adaptive Theme